Latham Helps TJC Clinch 2nd Continuation Fund At $2.1B

By Jade Martinez-Pogue · October 1, 2024, 1:27 PM EDT

Latham & Watkins LLP-advised middle-market private equity firm TJC LP on Tuesday announced that it clinched its second continuation fund with $2.1 billion of investor commitments led by Carlyle subsidiary AlpInvest....

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Recent Articles By Jade

September 25, 2024
Cancer Detection Biz To Go Public Via $694M SPAC Merger
September 23, 2024
RSV Vaccine Biz Secures $100M For Series B Funding Round
September 20, 2024
Cardinal Health Pays $1.12B For Integrated Oncology Network
September 18, 2024
Organon To Buy Psoriasis Treatment Biz For Up To $1.2B
September 09, 2024
MBX Biosciences Seeks Up To $136M In Upcoming IPO
September 03, 2024
Aspire Biopharma Inks SPAC Deal At $316M Valuation
September 03, 2024
Semnur Pharmaceuticals To Go Public Via $2.5B SPAC Merger
August 30, 2024
Cancer Detection Co. Valued At $375M In SPAC Merger
August 26, 2024
McKesson Inks $2.49B Deal For Cancer-Focused Biz
August 23, 2024
Covington-Led Getinge Pays $477M For Organ Transplant Biz